Positive FND diagnosis and precise assessment of swollen optic discs
Papilloedema is not a synonym for swollen optic discs; it specifically means optic disc swelling caused by raised intracranial pressure.
Two neurological diagnostic themes frame today’s briefing. Functional neurological disorder should be diagnosed using positive clinical features rather than treated as the label left after every investigation is normal. Naming the condition clearly and explaining that symptoms are real, brain-based and clinically recognised can reduce stigma. Shared language across neurology, psychology, physiotherapy, occupational therapy and speech therapy also helps prevent fragmented or contradictory explanations.
Swollen optic discs require equally precise terminology. Papilloedema specifically means optic disc swelling caused by raised intracranial pressure; optic nerve drusen, tilted discs, myelinated nerve fibres and optic neuropathies can produce alternative appearances. Fundus examination, optical coherence tomography and formal visual fields provide complementary information. Spontaneous venous pulsation supports normal intracranial pressure when present, but its absence is not diagnostic. In pulse-synchronous tinnitus, a change with gentle jugular compression supports a venous-flow mechanism.
The wider practical neurology material reinforces active enquiry during follow-up. Parkinson’s care should include sleep, mood, constipation, orthostatic symptoms, exercise, diet, driving and social function rather than focusing only on tremor or levodopa dose. Bladder, bowel and sexual dysfunction are frequently under-reported and need direct, neutral questioning. In neurocritical care, a normal sub-hairline EEG should not override ongoing clinical concern because limited scalp coverage can miss posterior or parasagittal seizure activity.
Iron deficiency provides the haematology and physiology thread. Reactive thrombocytosis appears to reflect a targeted shift within megakaryocytic-erythroid progenitors towards platelet production, together with larger and more polyploid megakaryocytes. The finding should still be interpreted clinically: iron studies, bleeding history, inflammation and other reactive causes matter. Correcting the iron deficiency addresses both the anaemia and the stimulus for thrombocytosis.
The lupus episode adds a trial-appraisal problem. Dapirolizumab pegol blocks CD40 ligand signalling, affecting B-cell, T-cell and interferon-related pathways. Although PHOENYCS-GO met its week 48 BICLA primary endpoint, failure of the earlier week 24 endpoint within the statistical hierarchy limits formal claims about later outcomes. Composite responses do not reveal which symptoms improve for an individual patient, and treatment decisions must also consider hypersensitivity, thromboembolic risk, infection, infusion logistics and the absence of clear patient-reported outcomes.
Neurology, psychiatry, rehabilitation and medical-education teams get a concise update on functional neurological disorder as a common, legitimate neurological condition. Positive rule-in clinical features, a coherent brain-based explanation, non-stigmatising language and shared multidisciplinary teaching support earlier diagnosis and clearer patient communication.
Neurology, ophthalmology and critical-care clinicians get a broad practical update covering swollen optic discs, Parkinson’s disease follow-up, neurogenic bladder, bowel and sexual symptoms, pulsatile tinnitus and rapid EEG monitoring. It emphasises diagnostic mimics, active enquiry about quality-of-life symptoms and the limited electrode coverage of sub-hairline EEG.
Haematology and basic-science learners get a mechanism-led explanation of reactive thrombocytosis in iron deficiency. A shift from erythroid towards megakaryocyte differentiation, increased megakaryocyte polyploidy and platelet release within the pulmonary circulation help explain why platelet counts can rise without a large increase in megakaryocyte number.
Rheumatology and critical-appraisal clinicians get an update on dapirolizumab pegol, a CD40 ligand inhibitor studied in active moderate to severe non-renal systemic lupus erythematosus. PHOENYCS-GO met its week 48 BICLA endpoint, but hierarchical testing, limited patient-reported outcomes, safety signals and four-weekly infusion burden complicate its clinical interpretation.
When optic discs appear swollen, document the visual symptoms and examination findings before applying the label of papilloedema, and use optical coherence tomography or formal visual fields where appropriate. In unexplained neurological presentations, look actively for positive features supporting FND and explain the diagnosis using direct, validating language. When thrombocytosis accompanies iron deficiency, review iron studies and possible bleeding rather than treating the platelet count as an isolated abnormality.
A patient has headache, transient visual obscurations and bilateral swollen optic discs. What does papilloedema mean, and what diagnostic caution is required?
Papilloedema means optic disc swelling caused by raised intracranial pressure. Swollen discs alone do not prove raised pressure or idiopathic intracranial hypertension because pseudopapilloedema and other optic nerve disorders can produce similar appearances.
A patient has neurological symptoms with positive examination features supporting functional neurological disorder and normal structural imaging. What should form the basis of the diagnosis?
Positive rule-in clinical features should support the diagnosis. Normal tests may help assess alternatives, but FND should not be presented simply as a diagnosis of exclusion.
A patient with iron deficiency develops reactive thrombocytosis. What mechanism helps explain the raised platelet count?
Iron deficiency can shift megakaryocytic-erythroid progenitors towards megakaryocyte differentiation and increase megakaryocyte polyploidy and platelet output. The rise does not necessarily require a large increase in megakaryocyte number.
.svg)